MDM2 and colorectal carcinoma: Similarly, Nutlin-3 also showed a greater selectivity toward PTEN-/- CRC cells in both HCT116 and RKO isogenic pairs (Figure G-H), demonstrating that MDM2 inhibitors induce synthetic lethality in PTEN-deficient CRC cells.